Tweenvest Stocks

Celon Pharma S.A. (WSE: CLN)

Health Care · Pharmaceuticals · PL

zł18.96

+1.39% today · -16.5% 1Y

Celon Pharma S.A. (WSE: CLN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $257.06M and employs 562 people.

Over the last twelve months the share price has lost 16.5%, trading between 18.00 and 23.50.

Tweenvest scores Celon Pharma S.A. across four factors: quality 71/100, value 56/100, growth 71/100. Its strongest factor is quality.

CLN price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$257.06M
Revenue (TTM)
$68.47M
P/E
9.17
EPS
2.04
Dividend yield
—
Beta (5Y)
0.62
52-week high
zł23.50
52-week low
zł18.00
Avg volume (3M)
—
Shares outstanding
53.86M
Employees
562
Next earnings
—

About Celon Pharma S.A.

Celon Pharma S.A. operates as a fully-integrated pharmaceutical firm, undertaking the investigation, development, production, and distribution of diverse medicinal formulations. Its business model is structured around two principal areas: generic drug offerings and innovative therapeutic solutions. The company's product line addresses a range of health challenges, including oncological conditions, neurological disorders, diabetes, and other metabolic complaints. Established in 2002, this enterprise is situated in Lomianki, Poland, and functions as a subsidiary of Glatton Sp. z o.o.

ISIN
PLCLNPH00015
Founded
2002
Listed since
Feb 17, 2017
Exchange
Warsaw Stock Exchange
Currency
PLN
CompanyMarket capPriceDay
Duopharma Biotech BerhadKLSE: DPHARMA$266.04MRM1.13-0.88%
Fredun Pharmaceuticals LimitedBSE: 539730$265.41MRs1,553.15+14.79%
Guangdong Jiaying Pharmaceutical Co., LtdSZSE: 002198$263.47MCN¥3.55-0.84%
Hunan Nucien Pharmaceutical Co., Ltd.SHSE: 688189$261.09MCN¥6.41-0.47%
Kwang Dong Pharmaceutical Co., Ltd.KOSE: A009290$255.84M₩6,920.00+5.65%
ACC Aviation Holdings Ltd.OTCPK: CAVG$254.46M$0.51—
Dong-A ST Co., Ltd.KOSE: A170900$250.58M₩34,950.00+1.45%
Jacobson Pharma Corporation LimitedSEHK: 2633$247.24MHK$0.97-0.51%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.